Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

(2015) A Ruggeri et al.   BONE MARROW TRANSPLANTATION

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

(2015) Alessandro Rambaldi et al.   LANCET ONCOLOGY

Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning

(2014) Olle Ringdén et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia

(2014) N H Russell et al.   LEUKEMIA

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

(2014) J J Cornelissen et al.   LEUKEMIA

Comparison of Reduced-Intensity and Myeloablative Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: A Meta-Analysis

(2014) S. Fadilah Abdul Wahid et al.   STEM CELLS AND DEVELOPMENT

Providing Personalized Prognostic Information for Adult Leukemia Survivors

(2013) Stephanie J. Lee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Surviving the cure: long term followup of hematopoietic cell transplant recipients

(2013) N S Majhail et al.   BONE MARROW TRANSPLANTATION

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with

(2012) R Martino et al.   BONE MARROW TRANSPLANTATION

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

(2012) Martin Bornhäuser et al.   LANCET ONCOLOGY

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced

(2012) A Shimoni et al.   LEUKEMIA

Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need

(2011) Avichai Shimoni et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

(2011) S M Luger et al.   BONE MARROW TRANSPLANTATION

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

(2011) John R. Wingard et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study

(2010) C.-L. Sun et al.   BLOOD

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

(2009) Olle Ringdén et al.   JOURNAL OF CLINICAL ONCOLOGY